This article was originally published in The Tan Sheet
NIH center seeks applications to characterize standardized versions of echinacea, feverfew, milk thistle and valerian root. The grantees also would be required to develop the capability to provide the standardized botanicals for NIH-sponsored trials, the RFA states. One award will be made for each herb, with awards totaling $6 mil. over three years. NCCAM's advisory council unanimously approved the initiative in January (1"The Tan Sheet" Jan. 31, p. 6). Letters of intent are due by Sept. 7, the application deadline is Nov. 14
You may also be interested in...
The National Advisory Council for Complementary & Alternative Medicine unanimously approved an initiative to characterize standardized versions of echinacea, feverfew, milk thistle and valerian root that could be used in Phase II/III clinical trials. The initiative, entitled "Natural Products Development," was discussed at a meeting held Jan. 24-25 in Rockville, Md.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning